Recent Quotes

Iterum Therapeutics PLC is a pharmaceutical company. The company is engaged in developing and commercializing sulopenem to be the first and only oral and intravenous branded penem available globally. Its sulopenem program has the potential to offer a solution to the problem of antibiotic resistance and the toxicity limitations of existing agents.

Earnings

Q2 2021		Est.		Actual		Surprise
EPS		(EXPECTED)2021-08-13
REV		(EXPECTED)2021-08-13

Q1 2021		Est.		Actual		Surprise
EPS		-0.070		-0.050		0.0200
REV				0

Analyst Ratings

Date	Analyst Firm	Analyst Name	Action	Rating	Action Price	Prior Price	Target

Related Companies

Ticker	Company	Price	Change	Chg %		Mkt Cap
ITRM	Iterum Therapeutics	0.87	0.12	16.79%		155.6M

Iterum Therapeutics Frequently Asked Questions

How do I buy Iterum Therapeutics (ITRM) stock?

You can purchase shares of Iterum Therapeutics (NASDAQ: ITRM) through any online brokerage.

View our list of the best stock brokerages.

Who are Iterum Therapeutics's (ITRM) competitors?

Other companies in Iterum Therapeutics’s space includes: Cocrystal Pharma (NASDAQ:COCP), SCYNEXIS (NASDAQ:SCYX), Lipocine (NASDAQ:LPCN), Qilian Intl Hldg Gr (NASDAQ:QLI) and Aquestive Therapeutics (NASDAQ:AQST).

What is the target price for Iterum Therapeutics (ITRM) stock?

The latest price target for Iterum Therapeutics (NASDAQ: ITRM) was reported by Gabelli & Co. on July 27, 2021. The analyst firm set a price target for 0.00 expecting ITRM to fall to within 12 months (a possible -100.00% downside). 5 analyst firms have reported ratings in the last year.

Current Stock Price for Iterum Therapeutics (ITRM)?

The stock price for Iterum Therapeutics (NASDAQ: ITRM) is $0.8687 last updated Thu Jul 29 2021 20:00:02 GMT+0000 (Coordinated Universal Time).

Does Iterum Therapeutics (ITRM) pay a dividend?

There are no upcoming dividends for Iterum Therapeutics.

When is Iterum Therapeutics (NASDAQ:ITRM) reporting earnings?

Iterum Therapeutics’s Q2 earnings are confirmed for after-market on August 13, 2021.

Is Iterum Therapeutics (ITRM) going to split?

There is no upcoming split for Iterum Therapeutics.

What sector and industry does Iterum Therapeutics (ITRM) operate in?

Iterum Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.